This is the first report that shows that the chemically engineered gold nanoparticles conjugated with citrate inhibit IFN-γ induced SOCS1 mRNA/protein expression via modulating miRNA-155-5p in triple-negative human breast cancer cells (Figure 10). The gene discussed is IFNG; the disease is breast cancer.